Working… Menu

WT-1 Analog Peptide Vaccine in Malignant Pleural Mesothelioma After Combined Modality Therapy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01265433
Recruitment Status : Completed
First Posted : December 23, 2010
Last Update Posted : November 5, 2018
United States Department of Defense
Information provided by (Responsible Party):
Sellas Life Sciences Group

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 25, 2017
Actual Study Completion Date : July 25, 2017